Related Experiment Videos
Cancer chemotherapy using suicide genes
1Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Surgical Oncology Clinics of North America
|June 13, 1998
Summary
Suicide gene therapy uses a prodrug approach to eliminate cancer cells. This method involves introducing a gene into malignant cells to activate a nontoxic prodrug into a toxic agent, showing promise in clinical trials.
Area of Science:
- Oncology
- Gene Therapy
- Pharmacology
Background:
- Suicide gene therapy is a novel drug delivery system for cancer treatment.
- It utilizes a prodrug approach for negative selection of malignant cells.
- The herpes simplex virus thymidine kinase gene (HSV-tk) is a prototype system.
Purpose of the Study:
- To explore the potential of suicide gene therapy in cancer treatment.
- To summarize the mechanism of prodrug activation within malignant cells.
- To highlight ongoing advancements in delivery systems and efficacy.
Main Methods:
- Transduction of malignant cells with a gene encoding a specific enzyme.
- Administration of a nontoxic prodrug that is metabolized into a toxic agent.
- Utilizing viral or nonviral vectors for gene delivery into tumor cells.
Main Results:
- The engineered enzyme converts the prodrug into a cytotoxic metabolite.
- This leads to targeted killing of malignant cells expressing the introduced gene.
- The strategy is currently being evaluated in clinical trials for various tumors.
Conclusions:
- Suicide gene therapy presents a promising strategy for cancer treatment.
- Further research is focused on optimizing delivery and metabolite production for enhanced efficacy.
- The approach holds potential for targeted cancer therapy with reduced systemic toxicity.